TM4SF19 (transmembrane 4 L six family member 19) is a membrane protein that serves multiple regulatory functions across different cellular contexts. The protein negatively regulates vacuolar H+-ATPase activity by interacting with V0 complex members and inhibiting V1-V0 complex assembly, while being required for multinucleation during osteoclast differentiation according to UniProt annotations. In vascular biology, TM4SF19 disrupts endothelial barrier function by suppressing VE-cadherin expression and attenuating adherens junctions in response to inflammatory stimuli 1. In cancer biology, TM4SF19 promotes oncogenic processes through transcriptional regulation - specifically controlling YAP transcription via interaction with the GABP transcription factor complex, where oxidative stress induces TM4SF19 dimerization and topology inversion, protecting GABPβ1 from proteasomal degradation 2. The gene shows clinical significance as a potential biomarker, being upregulated in various cancers including head and neck squamous cell carcinoma and oral squamous cell carcinoma, where higher expression correlates with advanced clinical stage and lymph node metastasis 3. Additionally, TM4SF19 variants show significant association with psychiatric disorders including schizophrenia and autism spectrum disorder in Japanese populations 4. The protein's diverse roles span from basic cellular processes like V-ATPase regulation to complex disease mechanisms involving inflammation, cancer progression, and neuropsychiatric conditions.